PG
SRDX

PEAK6 Group’s Surmodics SRDX Stock Holding History

PEAK6 Group’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.78M Buy
32,200
+11,900
+59% +$550K 0.01% 1457
2018
Q1 		$772K Buy
+20,300
New +$629K ﹤0.01% 2199
2017
Q4 		– Sell
-600
Closed -$19K – 4751
2017
Q3 		$19K Sell
600
-4,200
-88% -$114K ﹤0.01% 4183
2017
Q2 		$135K Buy
+4,800
New +$116K ﹤0.01% 3664
2014
Q3 		– Sell
-13,400
Closed -$287K – 5130
2014
Q2 		$287K Sell
13,400
-12,200
-48% -$261K ﹤0.01% 2858
2014
Q1 		$579K Buy
25,600
+1,000
+4% +$24.4K 0.01% 2416
2013
Q4 		$600K Buy
24,600
+5,800
+31% +$137K ﹤0.01% 2515
2013
Q3 		$224K Buy
+18,800
New +$403K ﹤0.01% 3589

Other funds holding SRDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Group's SRDX Position: Q4 2017 in Review

PEAK6 Group sold out of Surmodics (SRDX) in Q4 2017, closing a stake of 460 shares — an estimated $14K sold.

PEAK6 Group first reported a position in SRDX in Q3 2013 and held it in 3 quarters. The position peaked at $44K in Q3 2013. 115 funds tracked by Wall St. Rank hold SRDX as of Q4 2017.

  • PEAK6 Group reported no remaining Surmodics position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 460 Surmodics shares in Q4 2017, an estimated $14K.
  • PEAK6 Group first reported a position in Surmodics in Q3 2013 and held it in 3 quarters.
  • PEAK6 Group's Surmodics position peaked at $44K in Q3 2013.
  • 115 funds tracked by Wall St. Rank held Surmodics as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.